Table 1.
Clinicopathological characteristics of patients submitted to laparoscopic liver resection for hepatocellular carcinoma
| Characteristic | Patients assessed, n | Value |
|---|---|---|
| Age, years, median (range) | 351 | 63 (30–90) |
| Sex, male/female, n (%) | 351 | 260 (74%)/91 (26%) |
| Body mass index, kg/m2, median (range) | 194 | 26.4 (17.0–45.1) |
| α-fetoprotein, ng/ml, median (range) | 151 | 67 (0–65 000) |
| α-fetoprotein level ≥200 ng/ml, n (%) | 259 | 43 (17%) |
| American Society of Anesthesiologists (ASA) class, n (%) | 289 | |
| 1 | 47 (16%) | |
| 2 | 151 (52%) | |
| 3 | 90 (31%) | |
| 4 | 1 (0.003%) | |
| Child–Pugh class, n (%) | 284 | |
| A | 275 (97%) | |
| B | 8 (3%) | |
| C | 1 (0.003%) | |
| Known underlying liver disease, n (%) | 351 | 268 (76%) |
| Hepatitis B virus | 345 | 46 (13%) |
| Hepatitis C virus | 345 | 113 (33%) |
| Alcohol | 323 | 105 (33%) |
| Non-alcoholic steatohepatitis | 283 | 20 (7%) |
| Other | 283 | 60 (21%) |
| Preoperative transarterial chemoembolization, n (%) | 284 | 21 (7%) |
| Preoperative portal vein embolization, n (%) | 283 | 20 (7%) |
| Preoperative tumour biopsy, n (%) | 283 | 47 (17%) |